Forensic Analysis · Technology / Software · as of Aug 7, 2026
Oracle Corp (ORCL)
A forensic read on Oracle Corp built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
C · Mixed — selective
Forensic grade
Grey Zone
Financial health
2.6
Distress distance
Clean
Earnings quality
4
Forensic signals
24.4
P / E (ttm)
40.2%
ROE
$436.1B
Market cap
1.39%
Dividend yield
17.3%
Revenue growth
This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (red flags, auditor quality, say on pay, board independence). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.
Oracle Corp earns a C (Mixed — selective) forensic quality grade, and its balance-sheet distress test reads 2.6, placing it in the Grey zone. 4 forensic signals were flagged in its latest SEC filings, led by accruals ratio (% of noa).
What the filings flag
+29.9%
FY2025→FY2026
Accruals ratio (% of NOA).Net operating assets grew +29.9% relative to their own average in FY2026 — scaled by NOA itself, not total assets (see the Forensic Screens card's differently-scaled Sloan Accrual Ratio for that read). Accruals are building sharply — a large slice of profit sits in operating assets, not cash; Richardson/Sloan link high accruals to weaker future returns as they reverse. The build is led by PP&E up +130% against revenue +17% and receivables up +21% against revenue +17%. This is the third straight fiscal year of building accruals — a multi-year streak is a materially stronger tell than a single year's move. The cash-flow cross-check is more mixed: reported earnings ran behind operating cash by 12% of net operating assets, diverging from the balance-sheet accrual read.
+1.8%/yr
FY2023–FY2026
Share-count dilution.Diluted share count changed +5% over the last 3 years to FY2026 (+1.8%/yr). A change of direction: the count shrank over the full period (net -3.9%/yr since FY2012) but has grown across the recent window, so the two figures point opposite ways — read the recent window on totals versus per-share, since the full-period rate no longer describes what the count is doing now. That's ~1.8% shaved off per-share growth every year — total profit has to grow that much just to keep earnings-per-share flat, and a stake held since FY2023 has been diluted ~5%.
FCF ($23.7B)
FY2026
Shareholder returns.Returned $5.9B to shareholders (buybacks + dividends) in FY2026, but free cash flow was ($23.7B) after capex — there was no free cash flow to fund the payout from at all, though operating cash flow alone was $32.0B — 18% of that. The entire return is coming from debt or cash reserves, not cash the business itself generated — a harder case than returns merely running ahead of free cash flow, since here there was none to run ahead of.
Key fundamentals
Latest Revenue$67.36B
Revenue Growth YoY+17.3%
Revenue CAGR (3yr)+10.5%
Net Margin25.4%
Free Cash Flow-$23.69B
Return on Equity40.2%
Debt / Equity3.05x
The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Oracle Corp's actual 10-K/10-Q/8-K filings?
Data from SEC EDGAR public filings · metrics as of Aug 7, 2026. Forensic signals flag probability, not certainty.
8.3%
FY2026
Return on invested capital.Return on invested capital is 8.3% in the latest fiscal year and steady — slightly below its ~10% cost of capital — reinvestment is roughly a wash.